(CRH) CRH - Ratings and Ratios
Cement, Aggregates, Concrete, Asphalt, Precast Concrete
Description: CRH CRH
CRH PLC ADR (NYSE:CRH) is a leading global building materials company operating across three main segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions. The company provides a wide range of products and services for the construction and maintenance of infrastructure, commercial, and residential buildings.
From a business perspective, CRHs diversified product portfolio includes aggregates, cement, ready-mixed concrete, asphalt, precast concrete products, and engineered steel and polymer-based solutions. The companys products cater to various markets, including water, energy, transportation, and telecommunications projects. Additionally, CRH offers paving and construction services, as well as fencing and railing systems, composite decking, and lawn and garden products.
To evaluate CRHs performance, key performance indicators (KPIs) such as revenue growth, operating margins, and return on equity (RoE) can be analyzed. With a RoE of 15.42%, CRH demonstrates a decent return on shareholders equity. Other relevant KPIs include debt-to-equity ratio, interest coverage ratio, and dividend yield, which can provide insights into the companys capital structure, financial health, and investor returns.
CRHs operational efficiency can be assessed by examining metrics such as capacity utilization, production costs, and pricing power. The companys ability to manage its supply chain, invest in research and development, and adapt to changing market conditions will be crucial in maintaining its competitive edge. Furthermore, CRHs geographic diversification across Ireland, the United States, the United Kingdom, and other regions helps mitigate regional market risks.
To further analyze CRHs stock, investors can examine valuation multiples such as the price-to-earnings (P/E) ratio, which currently stands at 20.03. Comparing this to the industry average and CRHs historical P/E ratio can help determine if the stock is fairly valued. Additionally, investors can assess CRHs dividend policy, payout ratio, and history of dividend growth to gauge the sustainability of its dividend payments.
CRH Stock Overview
| Market Cap in USD | 74,947m |
| Sub-Industry | Construction Materials |
| IPO / Inception | 1993-02-19 |
CRH Stock Ratings
| Growth Rating | 69.4% |
| Fundamental | 57.6% |
| Dividend Rating | 50.8% |
| Return 12m vs S&P 500 | 9.20% |
| Analyst Rating | 4.43 of 5 |
CRH Dividends
| Dividend Yield 12m | 1.42% |
| Yield on Cost 5y | 4.53% |
| Annual Growth 5y | 8.67% |
| Payout Consistency | 92.7% |
| Payout Ratio | 29.5% |
CRH Growth Ratios
| Growth Correlation 3m | 92.2% |
| Growth Correlation 12m | 27.4% |
| Growth Correlation 5y | 84.3% |
| CAGR 5y | 28.32% |
| CAGR/Max DD 5y | 0.71 |
| Sharpe Ratio 12m | 1.02 |
| Alpha | 11.28 |
| Beta | 1.041 |
| Volatility | 27.21% |
| Current Volume | 4067.1k |
| Average Volume 20d | 4067.1k |
| Stop Loss | 107.9 (-3%) |
| Signal | 2.17 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (2.91b TTM) > 0 and > 6% of Revenue (6% = 1.98b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -1.44pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 19.64% (prev 14.02%; Δ 5.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 4.53b > Net Income 2.91b (YES >=105%, WARN >=100%) |
| Net Debt (14.28b) to EBITDA (6.45b) ratio: 2.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (677.7m) change vs 12m ago -1.61% (target <= -2.0% for YES) |
| Gross Margin 35.89% (prev 34.86%; Δ 1.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 64.52% (prev 67.71%; Δ -3.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.28 (EBITDA TTM 6.45b / Interest Expense TTM 639.3m) >= 6 (WARN >= 3) |
Altman Z'' 3.70
| (A) 0.12 = (Total Current Assets 15.15b - Total Current Liabilities 8.68b) / Total Assets 53.98b |
| (B) 0.45 = Retained Earnings (Balance) 24.11b / Total Assets 53.98b |
| (C) 0.09 = EBIT TTM 4.65b / Avg Total Assets 51.04b |
| (D) 0.80 = Book Value of Equity 24.39b / Total Liabilities 30.35b |
| Total Rating: 3.70 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.59
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 2.27% = 1.14 |
| 3. FCF Margin 6.08% = 1.52 |
| 4. Debt/Equity 0.72 = 2.25 |
| 5. Debt/Ebitda 2.49 = -0.93 |
| 6. ROIC - WACC 1.47% = 1.84 |
| 7. RoE 13.41% = 1.12 |
| 8. Rev. Trend -31.09% = -1.55 |
| 9. Rev. CAGR -1.35% = -0.23 |
| 10. EPS Trend -11.41% = -0.29 |
| 11. EPS CAGR 12.30% = 1.23 |
What is the price of CRH shares?
Over the past week, the price has changed by -2.62%, over one month by +13.68%, over three months by +22.71% and over the past year by +28.22%.
Is CRH a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRH is around 121.99 USD . This means that CRH is currently overvalued and has a potential downside of 9.62%.
Is CRH a buy, sell or hold?
- Strong Buy: 14
- Buy: 5
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CRH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 117.3 | 5.4% |
| Analysts Target Price | 111.6 | 0.3% |
| ValueRay Target Price | 135.7 | 22% |
Last update: 2025-08-20 02:49
CRH Fundamental Data Overview
CCE Cash And Equivalents = 2.88b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 23.3816
P/E Forward = 19.7628
P/S = 2.062
P/B = 3.3543
P/EG = 2.6352
Beta = 1.195
Revenue TTM = 32.93b USD
EBIT TTM = 4.65b USD
EBITDA TTM = 6.45b USD
Long Term Debt = 14.64b USD (from longTermDebt, last quarter)
Short Term Debt = 1.42b USD (from shortTermDebt, last quarter)
Debt = 16.06b USD (Calculated: Short Term 1.42b + Long Term 14.64b)
Net Debt = 14.28b USD (from netDebt column, last quarter)
Enterprise Value = 88.13b USD (74.95b + Debt 16.06b - CCE 2.88b)
Interest Coverage Ratio = 7.28 (Ebit TTM 4.65b / Interest Expense TTM 639.3m)
FCF Yield = 2.27% (FCF TTM 2.00b / Enterprise Value 88.13b)
FCF Margin = 6.08% (FCF TTM 2.00b / Revenue TTM 32.93b)
Net Margin = 8.85% (Net Income TTM 2.91b / Revenue TTM 32.93b)
Gross Margin = 35.89% ((Revenue TTM 32.93b - Cost of Revenue TTM 21.11b) / Revenue TTM)
Tobins Q-Ratio = 3.61 (Enterprise Value 88.13b / Book Value Of Equity 24.39b)
Interest Expense / Debt = 1.06% (Interest Expense 170.7m / Debt 16.06b)
Taxrate = 23.56% (1.05b / 4.45b)
NOPAT = 3.56b (EBIT 4.65b * (1 - 23.56%))
Current Ratio = 1.74 (Total Current Assets 15.15b / Total Current Liabilities 8.68b)
Debt / Equity = 0.72 (Debt 16.06b / last Quarter total Stockholder Equity 22.34b)
Debt / EBITDA = 2.49 (Net Debt 14.28b / EBITDA 6.45b)
Debt / FCF = 8.02 (Debt 16.06b / FCF TTM 2.00b)
Total Stockholder Equity = 21.74b (last 4 quarters mean)
RoA = 5.40% (Net Income 2.91b, Total Assets 53.98b )
RoE = 13.41% (Net Income TTM 2.91b / Total Stockholder Equity 21.74b)
RoCE = 12.79% (Ebit 4.65b / (Equity 21.74b + L.T.Debt 14.64b))
RoIC = 9.73% (NOPAT 3.56b / Invested Capital 36.57b)
WACC = 8.26% (E(74.95b)/V(91.01b) * Re(9.85%)) + (D(16.06b)/V(91.01b) * Rd(1.06%) * (1-Tc(0.24)))
Shares Correlation 5-Years: -100.0 | Cagr: -3.59%
Discount Rate = 9.85% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 68.03% ; FCFE base≈2.19b ; Y1≈1.80b ; Y5≈1.28b
Fair Price DCF = 26.28 (DCF Value 17.66b / Shares Outstanding 672.0m; 5y FCF grow -21.77% → 3.0% )
Revenue Correlation: -31.09 | Revenue CAGR: -1.35%
Rev Growth-of-Growth: 14.95
EPS Correlation: -11.41 | EPS CAGR: 12.30%
EPS Growth-of-Growth: -69.63
Additional Sources for CRH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle